The Europe molecular diagnostics market is witnessing significant growth, driven by the increasing burden of infectious diseases and the rapid evolution of personalized medicine. Valued at US$ 5.9 billion in 2023, the market is projected to expand at a CAGR of 10.2% from 2024 to 2034, reaching an estimated US$ 17.3 billion by the end of the forecast period. This growth highlights the rising...